文献速递神经技术与安全MR

预测白质高信号:利用便携式MRI实现可及性脑健康筛查

Predicting White Matter Hyperintensity: Leveraging Portable MRI for Accessible Brain Health Screening.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-09-02

本研究在143例开发队列和127例验证队列中,基于0.064T便携式MRI的T2-FLAIR序列量化白质高信号(WMH)负荷,构建并验证了包含年龄、收缩压>140、心房颤动和吸烟的风险模型,预测WMH>10mL的AUC在开发队列为0.83、验证队列为0.85,便携式MRI与常规MRI的WMH体积一致性好(r=0.93)。

要点

  • 便携式MRI可定量测量WMH体积,与常规MRI一致性高(r=0.93)。
  • 风险模型含年龄、收缩压>140、心房颤动和吸烟,预测WMH>10mL的AUC为0.83–0.85。
  • 模型或有助于识别可从便携式MRI筛查中获益的高风险患者。

核心结论

  • WMH风险评分在两个队列中表现出准确的性能和可重复性,支持其作为识别中度WMH负荷风险患者的筛查工具的潜力;对高风险个体进行适当针对性的便携式MRI筛查可能使提供者和患者主动管理血管危险因素并改善神经结局。

研究设计与样本

  • 研究类型为风险模型开发与验证研究;开发队列n=143(前瞻性WMH筛查试点项目中的便携式MRI),验证队列n=127(回顾性收集的便携式MRI),验证队列中120例在便携式MRI后3个月内行常规MRI用于额外验证和设备一致性分析;使用0.064T便携式MRI轴位T2-FLAIR序列,以针对任意分辨率序列开发的WMH分割软件量化WMH负荷;采用后向选择筛选候选变量。

诊断标准与关键数值

  • 主要结局为WMH负荷大于10mL;最终模型纳入年龄、收缩压>140、心房颤动和吸烟,开发队列AUC为0.83(95%CI 0.75-0.90),验证队列AUC为0.85(95%CI 0.77-0.92),使用常规MRI来源WMH测量时AUC为0.86(95%CI 0.77-0.93,n=120,P=0.98);便携式MRI与常规MRI的WMH体积一致性r=0.93(95%CI 0.90-0.95,n=120,P<0.001)。

临床应用与阅片要点

  • 作者认为该WMH风险评分有潜力作为筛查工具识别中度WMH负荷风险患者,对高风险个体进行适当针对性的便携式MRI筛查可能使提供者和患者主动管理血管危险因素并改善神经结局。

局限性

  • 验证队列为回顾性收集的便携式MRI,获取目的不同。
  • 开发队列的便携式MRI来自急诊科前瞻性WMH筛查试点项目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Portable MRI (pMRI) has emerged as a cost-effective and accessible tool for the identification of white matter hyperintensities (WMH), an independent risk factor for stroke and dementia. Our objective was to confirm that pMRI can produce accurate WMH measurements and to develop and validate a risk model to predict WMH on pMRI for the purpose of identifying patients who may benefit from pMRI screening.

MATERIALS AND METHODS: The development (n = 143) and validation (n = 127) cohorts included patients without acute neurologic pathology who received a pMRI at a tertiary care hospital between May 2020 and July 2024. The development cohort included pMRIs collected as part of a prospective WMH screening pilot program in the emergency department. The validation cohort was a retrospective collection of pMRIs obtained for separate research purposes. Conventional MRIs (cMRIs) in the validation cohort obtained within 3 months of pMRIs were used for additional validation and device agreement. The primary outcome was WMH burden greater than 10 mL, assessed via an axial T2-FLAIR sequence acquired on a 0.064T pMRI and quantified by using a WMH segmentation software developed to process sequences of any resolution. We used backwards selection to screen candidate variables and report the area under the curve of the resulting model.

RESULTS: The final model, which included age, systolic blood pressure >140, atrial fibrillation, and tobacco use, achieved an area under the curve (AUC) of 0.83 (95% CI, 0.75-0.90) in the development cohort (n = 143, 62.4 ± 12.6 years, 44% female, 36% nonwhite race) and 0.85 (95% CI, 0.77-0.92) in the validation cohort (n = 127, 65.2 ± 16.8 years, 51% female, 34% nonwhite race), with similar results by using WMH measurements derived from cMRI (n = 120, P = .98, AUC = 0.86, 95% CI, 0.77-0.93). Additionally, we confirmed agreement in WMH volumes between pMRI and cMRI (n = 120, r = 0.93, 95% CI, 0.90-0.95, P < .001).

CONCLUSIONS: The WMH risk score demonstrated accurate performance and reproducibility across cohorts, supporting its potential as a screening tool for identifying patients at risk of moderate WMH burden. Appropriately targeted pMRI screening in high-risk individuals could allow providers and patients to proactively manage vascular risk factors and improve neurologic outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Johnson IP, Brigger H, Smith J, et al. Predicting White Matter Hyperintensity: Leveraging Portable MRI for Accessible Brain Health Screening. AJNR Am J Neuroradiol. 2025. PMID: 40081846. doi:10.3174/ajnr.A8734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。